1)Parkinson's disease帕金森氏病
1.Clinical data suggested their involvement in the pathogenesis of several cognition disorders,for example Alzheimer's disease(AD),Parkinson's disease(PD)and epilepsy.临床资料提示,nAChR与一些认知功能障碍性疾病的发病机制有关,如:阿尔茨海默病(AD)、帕金森氏病(PD)以及癫痫等。
2.Parkinson's disease (PD) characterised pathologically by the selective loss of dopaminergic neurons and the presence of Lewy bodies (LB) in the substantia nigra is the second most common neurodegenerative disorder after Alzheimer's disease, affecting people in mid and late life.帕金森氏病(Parkinson’s disease，PD)是一种常见的神经退行性疾病，其特征是黑质多巴胺能神经元选择性减少以及路易小体(Lewy body，LB)小体形成，多见于老年人。
英文短句/例句
1.The Study on Mechanism and Interfere Factors of Parkinson s Disease;帕金森氏病的发病机制及干预因素的研究
2.Relationship between Desensitized Nicotinic Acetylcholine Receptors and Parkinson s Disease;失敏态脑N受体与帕金森氏病关系的研究
3.The Protective Experiment of PD C57 Mice Induced by Paraquat;百草枯诱导C57小鼠帕金森氏病的保护性研究
4.Effect of Stereotactic Bilateral Multiple-target Combined with Radiofrequency Ablation on Parkinson's Disease立体定向多点毁损治疗帕金森氏病的疗效
5.Determination of brain iron content in patients with Parkinson’ s disease using magnetic susceptibility imaging磁敏感成像检测帕金森氏病脑铁沉积(英文)
6.Gender Difference in Incidence of Parkinson's Disease and the Possible Mechanism in PD Model帕金森氏病发病率的性别差异及机制的动物实验研究
7.The Study of Motor Evoked Potential in Parkinson s Disease by Transcranial Magnetic Stimulation;经颅磁刺激对帕金森氏病患者的运动诱发电位的研究
8.RECENT FINDINGS: The involvement of inflammatory mechanisms in Parkinson's disease has been revealed through in-vitro and in-vivo experimental studies supported by pathological and epidemiological findings.病理学和流行病学的发现支持通过体外和体内实验揭示的帕金森氏病炎症机制假说。
9.But preliminary studies of Parkinson's patients suggest that pig cells may work as well as those from human fetuses.不过，对帕金森氏病人的初步研究表明，猪细胞与人胚胎细胞所起的功能一样好。
10.Doctors are implanting devices directly into the brain to help patients cope with Parkinson's disease.医师把仪器植入脑部，帮助病人对抗帕金森氏症。
11.Clinical Research of Parkinson's Disease with Shi's Combination Therapy of Bian-stone and Acupuncture施氏砭术综合疗法治疗帕金森病的临床研究
12.Many victims of the disease had symptoms similar to Parkinson's disease.许多患有此病的人有着与帕金森氏综合症相似的症状，
13.Although the causes of idiopathic Parkinson's disease remain a mystery, there are other forms of Parkinson's disease.虽然造成先天性帕金森氏综合症的病因还是个谜，
14.Their physical changes were caused by a sickness known as Parkinson's disease.他们的身体变化是由于一种叫做帕金森氏综合症的疾病造成的。
15.Wolff-Parkinson-White syndrome沃尔弗－帕金森－怀特氏综合症
16.Scientists say treatment of diseases such as Alzheimer's and Parkinson's9 will be the first application of therapeutic10 cloning.科学家们说，以治疗为目的的克隆技术将首先用来治疗阿尔兹海默氏病和帕金森氏
17.For example, Parkinson's, Alzheimer's and Huntington's diseases are caused by the death of specific cells in the brain.例如，帕金森氏症、阿尔茨海默氏症和亨廷顿疾病，都是由特殊脑细胞死亡引起的。
18."The cause of primary parkinsonism, or Parkinson disease, is unknown. The mean age of onset is about 57, But juvenile parkinsonism is also known."帕金森氏症的原因不清楚。平均发病年龄是57岁,但是也有少年的病例。
相关短句/例句
parkinson disease帕金森氏病
1.The character of Parkinson disease rat model after 6-hydroxydopamine injection in different regions;6-羟基多巴不同部位毁损大鼠帕金森氏病模型的建立及比较
2.Objective:To study the effect of the location of computer-assistant stereotactic operation combined with the electrophysiological-stimulation in thalamotomy and pallidotomy to treat the parkinson disease(PD).目的 :研究计算机辅助立体定向脑内靶点定位与术中电生理刺激结合确定丘脑腹外侧核 (VL)、苍白球腹后外侧部 (VPLP)在治疗帕金森氏病 (PD)中的作用。
3.Objective To research a method of selecting PD gene based on microarray dataset from multiplex 3D brain gene expression mapping in order to obtain the vivid insights into molecular pathogenesis of Parkinson disease(PD).目的为了研究帕金森氏病发病机理,探索从多元三维脑基因表达图谱的基因芯片数据中提取帕金森氏病的基因的方法。
3)Parkinson's disease (PD)帕金森氏病
4)antiparkinsonism drugs抗帕金森氏病药
5)antiparkinsonian['?nti,pɑ:kin's?uni?n]抗帕金森氏病的
6)Parkinson's disease帕金森病
1.Effect of Salidroside on PI3K/protein kinase B signaling in Parkinson's disease model mice;红景天甙对帕金森病模型小鼠PI3K/蛋白激酶B信号转导途径的影响
2.Progression of MRI study on olfactory dysfunction of Parkinson's disease;帕金森病嗅觉障碍的MRI研究进展
延伸阅读
抗帕金森氏病药分子式：CAS号：性质：又称抗帕金森氏病药。其主要病理改变是黑质内多巴胺(DA)神经元变性坏死，使纹状体内DA功能降低而乙酰胆碱(Ach)功能相对增强而出现病症。因而抗帕金森氏病药主要分为拟多巴胺(拟DA)药，如左旋多巴、金刚烷胺、溴隐亭等和中枢抗胆碱药，如苯海索开马君等。此外如卡比多巴是一种外周性脱羧酶抑制剂，在外周抑制左旋多巴脱羧，降低外周DA的生成，与左旋多巴合用，可提高疗效，降低剂量，减少副作用。
